Microplate Dx

Glasgow, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of a medical diagnostic device designed to reduce deaths from drug-resistant infections. Microplate Dx is based in Glasgow, United Kingdom and was founded in 2021. It was valued at $11.9 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $14 million across 2 recorded rounds; the latest was a $644,569 seed round in Sep 2025.

PMV mark · valuation
$11.9M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$14.0M
Last round
Seed Round
Sep 2025

Who backs Microplate Dx?

15 investors
InvestorType
MedTech InnovatorOther
Scottish EnterpriseGrowth equity
Impact VentureFamily office
University of Strathclyde EndowmentOther
Converge Challenge—
ICURe—
Incate—
National Institute for Health Research Invention for Innovation—
SBRI Healthcare—
SE High Growth Spin-out Programme—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Microplate Dx investors

15 investors are on record for Microplate Dx, including MedTech Innovator, Scottish Enterprise, Impact Venture and University of Strathclyde Endowment. The seed round in Sep 2025 drew 3 investors.

Free account
More of Microplate Dx with a free account
  • ·The complete investor list: 15 names
  • ·Watch Microplate Dx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Microplate Dx. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View